Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
Use this KURA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KURA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KURA SEC filings page. Lician reads the product cache first so this HTML stays unique to Kura Oncology Inc even when a live quote feed is slow.
Latest cached year on this hub. Full KURA income, balance, and cash tables.